NOTHING LASTS LONGER Trademark Information

Trademark by Celltech Pharmaceuticals, Inc.

Printed matter, namely, newsletters, brochures and newspapers published for patients, consumers, health care providers,and pharmacists about pharmaceutical preparations used to treat coughs and colds in International Class 16.

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (016)
Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks.
First Use Anywhere:: 2/17/2003
First Use In Commerce: 2/17/2003
General Information
Word mark: NOTHING LASTS LONGER
Status/Status Date:
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
6/29/2005
Serial Number: 78220368
Filing Date: 2/28/2003
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Printed matter, namely, newsletters, brochures and newspapers published for patients, consumers, health care providers,and pharmacists about pharmaceutical preparations used to treat coughs and colds in International Class 16.
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: N/A
Last Applicant/Owner:
Celltech Pharmaceuticals, Inc.
Rochester 14623
Mark Drawing Code: Typeset (Words/letter/Number)
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
Celltech Americas, Inc.
755 Jefferson Rd. Legal Affairs
Rochester NY USA 14623
Current Status:
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
6/29/2005
Correspondent Search:
Kim M. Shaffer, Esq. is a correspondent of NOTHING LASTS LONGER trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on